pone.0259449.g003.tif (129.45 kB)
RPL9 promoter DNA methylation by MetS status.
figure
posted on 2021-10-29, 17:37 authored by Keane Urashima, Anastasia Miramontes, Luis A. Garcia, Dawn K. ColettaDNA methylation at four CpGs within the promoter of RPL9 was measured in non-MetS (n = 110) and MetS (n = 74). Mann-Whitney U test was used for the statistical comparisons between the non-MetS versus MetS. *p < 0.05, **p < 0.01, ****p < 0.0001.
History
Usage metrics
Categories
Keywords
whitney u testtwo cpg sitesthree cpg sitestargeted approach focusingsignificant inverse relationshippresent study aimedimpaired glucose tolerancehighly prevalent worldwidefuture validation studiesepsilon subunit (<arizona insulin resistanceshowed decreased methylationmean methylation within20 decreased genesdiv >< phuman whole bloodlatinos 184 adult participantswhole bloodmethylation dataselect genesadult populationidentify bloodversus rpl9 cox6c atp5e united statesspearman ’smoking statusrpl9 )pyrosequencing analysispromoter regionpotential evidencemultiple phenotypesmolecular mechanismsmetabolic syndromelatino descentincluding obesityestimates showepigenetic biomarkerscox6c )correlation revealedcomplex diseaseatp5e )atp synthaseatp iii05 using05 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC